Skip to main content
. 2021 Oct 4;164(4):722–736. doi: 10.1111/imm.13416

FIGURE 1.

FIGURE 1

Timeline for the discovery of BTK highlighting key milestones in BTK‐related research and therapies. Each section represents a decade. Ac, acalabrutinib; CLL, chronic lymphocytic leukaemia; GVHD, graft‐versus‐host disease; Ib, ibrutinib; MCL, mantle cell lymphoma; MZL, marginal zone lymphoma; WM, Waldenström's macroglobulinaemia; XID, X‐linked immunodeficiency; XLA, X‐linked agammaglobulinaemia